Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Alloreactive T Cell Depletion Method For Preventing Graft-Versus-Host Disease
Case ID:
TAB-3013
Web Published:
12/6/2022
The invention relates to the use of adenosine to deplete alloreactive T cells from donor grafts to prevent graft-versus-host disease (GVHD). The method includes culturing donor cells that include T cells with recipient antigen presenting cells (APCs) to form a mixture of cells. The recipient’s APCs activate donor T cells. The activated T cells are treated with high doses of adenosine or an adenosine-like molecule to decrease or inhibit viability of the activated donor T-cells. The adenosine or adenosine-like molecule is filtered away from the mixture resulting in cells that can be transplanted into the recipient.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Alloreactive_T_Cell_Depletio n_Method_For_Preventing_Graft-Versus-Host_Disease
Keywords:
Alloreactive
Cell
DEPLETION
Disease
DONOR
GRAFTS
GRAFT-VERSUS-HOST
GVHD
Listed LPM Maddox as of 4/15/2015
LYMPHOCYTE
lymphocytes
Method
Novel
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
Prevent
SELECTIVE
Stem
T
YAXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Michael Shmilovich
Senior Licensing And Patenting Manager
NIH Technology Transfer
301-435-5019
shmilovm@nih.gov